Additional monitoring

by Thomas Underwood

March 10, 2020

Clinical Trial Outsourcing Trends and Research in 2020

Read the latest trends and predictions on clinical outsourcing and research due to new regulations and pressure to reduce the costs of drug development

Read more

by Statistical Consultancy Team

October 29, 2018

FDA Guidance for Human Gene Therapy for Hemophilia A & B

This blog post reviews the FDA's guidance for Human Gene Therapy (GT) for Hemophilia A & B clinical trials and what is needed to support an accelerated approval approach. Learn More

Read more

by Commercial Team

February 13, 2017

ICH GCP E6 Addendum R2 - What do you need to know?

Explore the ICHGCP E6 Addendum R2 changes and what they mean for sponsors and vendors in clinical trial conduct, risk-based monitoring and emerging technologies

Read more

by Thomas Underwood

August 16, 2016

The Rise of Risk Based Monitoring [Infographic]

This infographic presents survey data that indicates the increase in the use of risk-based monitoring and how data from trials using RBM solutions has risen

Read more

by Thomas Underwood

April 26, 2016

The Rise of Risk-Based Monitoring in Clinical Trials

This Quanticate blog post examines the rise of Risk Based Monitoring in clinical trials and growing trends from industry data in the adoption of RBM

Read more

by Statistical Consultancy Team

June 13, 2014

Efficient Data Reviews and Quality in Clinical Trials [Video]

A video of Kelci Miclaus from SAS JMP speaking at Clinical Data Live 2013, discussing Efficient Data Reviews and Quality in Clinical Trials.

Read more

by Pharmacovigilance Team

November 8, 2013

Pharmacovigilance - The Black Triangle and Additional Monitoring

A Quanticate blog exploring The Black Triangle symbol ▼ and Additional Monitoring in the new Pharmacovigilance legislation.

Read more